Bifidobacterium breve DSM 20213 = JCM 1192

Bifidobacterium breve DSM 20213 (also known as JCM 1192) is a Gram-positive, anaerobic bacterium that belongs to the genus Bifidobacterium, which is part of the diverse microbiota found in the gastrointestinal tracts of humans and other mammals. As an anaerobe, B. breve DSM 20213 thrives in environments devoid of oxygen, suggesting its adaptation to the anaerobic conditions prevalent in the human gut. This species is known for its beneficial role in promoting gut health and is often associated with probiotic properties. Its Gram-positive nature indicates a thick peptidoglycan layer, which may contribute to its resilience in the harsh gastrointestinal environment. Bifidobacterium breve species are recognized for their ability to ferment dietary fibers and produce short-chain fatty acids (SCFAs), which can play a crucial role in gut health by providing energy to colonocytes and influencing the composition of the gut microbiota. Given the well-documented association of Bifidobacterium species with health benefits, B. breve DSM 20213 may contribute to the modulation of gut microbiota composition, potentially enhancing the host's immune response and providing protection against gastrointestinal disorders. The unique ecological niche occupied by this microbe underscores its significance in maintaining a balanced gut environment, highlighting the importance of anaerobic bacteria in human health and microbiome research.